Cognitive presentation of multiple sclerosis: Evidence for a cortical variant

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 7, 2003, Pages 872-877

  Zarei, M ^b   Chandran, S ^b   Compston, A ^b   Hodges, John ^a,b  

^a MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMENTIA; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MEMORY DISORDER; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AMNESIA; CEREBRAL CORTEX; COGNITION DISORDERS; DEGLUTITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DISABLED PERSONS; DYSLEXIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SYNDROME;

EID: 0038480622     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.7.872     Document Type: Article

References (57)

1. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
2. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
3. Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 1998;8:43-77.
4. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995;8:216-20.
5. Peyser JM, Rao SM, LaRocca NG, et al. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 1990;47:94-7.
6. Lyon-Caen O, Jouvent R, Hauser S, et al. Cognitive function in recent-onset demyelinating diseases. Arch Neurol 1986;43:1138-41.
7. Swingler RJ, Compston DA. The morbidity of multiple sclerosis. Q J Med 1992;83:325-37.
8. Truelle JL, Palisson E, Le Gall D, et al. Intellectual and mood disorders in multiple sclerosis. Rev Neurol (Paris) 1987;143:595-601.
9. Ron MA, Callanan MM, Warrington EK. Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychol Med 1991;21:59-68.
10. Feinstein A, Youl B, Ron M. Acute optic neuritis. A cognitive and magnetic resonance imaging study. Brain 1992;115:1403-15.
11. Feinstein A, Ron M, Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 1993;116:569-602.
12. Skegg K. Multiple sclerosis presenting as a pure psychiatric disorder. Psychol Med 1993;23:909-14.
13. Matthews WB. Multiple sclerosis presenting with acute remitting psychiatric symptoms. J Neurol Neurosurg Psychiatry 1979;42:859-63.
14. Young AC, Saunders J, Ponsford JR. Mental change as an early feature of multiple sclerosis. J Neurol Neurosurg Psychiatry 1976;39:1008-13.
15. Goodstein RK, Ferrell RB, Multiple sclerosis - presenting as depressive illness. Dis Nerv Syst 1977;38:127-31.
16. Vighetto A, Charles N, Salzmann M, et al. Korsakoff's syndrome as the initial presentation of multiple sclerosis. J Neurol 1991;238:351-4
17. Averbuch-Heller L, Shalev AY, Abramowitz MZ. An unusual presentation of multiple sclerosis. Am J Psychiatry 1992;149:410-11.
18. Hotopf MH, Pollock S, Lishman WA. An unusual presentation of multiple sclerosis. Psychol Med 1994;24:525-8.
19. Clarke T, Wadhwa U, Leroi I. Psychotic depression. An atypical initial presentation of multiple sclerosis. Psychosomatics 1998;39:72-5.
20. Salloway S, Price LH, Charney DS, et al. Multiple sclerosis presenting as major depression: a diagnosis suggested by MRI scan but not CT scan. J Clin Psychiatry 1988;49:364-6.
21. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 1990;47:98-104.
22. Whitlock FA, Siskind MM. Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980;43:861-5.
23. McDonald WI, Ron MA. Multiple sclerosis: the disease and its manifestations. Philos Trans R Soc Lond B Biol Sci 1999;354:1615-22.
24. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000;126:413-31
25. Baxter LR, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243-50.
26. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.
27. Wu JC, Gillin JC, Buchsbaum MS, et al. Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992;149:538-43.
28. Sabatini U, Pozzilli C, Pantano P, et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry 1996;39:970-5.
29. Bakshi R, Czarnecki D, Shaikh ZA, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000;11:1153-8.
30. Janardhan V, Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol 2000;57:1485-91.
31. Zivadinov R, Sepcic J, Nasuelli D, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773-80.
32. Huber SJ, Shuttleworth EC. Neuropsychological assessment of subcortical dementia. In: Cumming JL, ed. Subcortical dementias. Oxford: Oxford University Press, 1990:71-86.
33. Salmon DP, Hodges JR. Neuropsychological assessment of early onset dementia. In: Hodges JR, ed. Early-onset dementia. Oxford: Oxford University press, 2001:47-73.
34. Rao SM. Multiple sclerosis. In: Cumming JL, ed. Subcortical dementias. Oxford: Oxford University Press, 1990:164-80.
35. Wilson HC, Scolding NJ, , Inflammatory and infective disorders. In: Hodges JR, ed. Early-onset dementia. Oxford: Oxford University press, 2001:385-7.
36. Moriarty DM, Blackshaw AJ, Talbot PR, et al. Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images. Am J Neuroradiol 1999;20:1956-62.
37. Paulesu E, Perani D, Fazio F, et al. Functional basis of memory impairment in multiple sclerosis: an [18F]FDG PET study. Neuroimage 1996;4:87-96.
38. Benedict RH, Bakshi R, Simon JH, et al. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2002;14:44-51.
39. Brownell B, Hughes JT, The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315-20.
40. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds Handbook of clinical neurology, vol 9. Amsterdam: Elsevier, 1970: 217-309.
41. Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26.
42. Peterson JW, Bo L, Mork S, et al. Transected neurities, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400.
43. Catalaa I, Fulton JC, Zhang X, et al. MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing. Am J Neuroradiol 1999;20:1613-18.
44. Camp SJ, Stevenson VL, Thompson AJ, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999;122:1341-8.
45. Boggild MD, Williams R, Haq N, et al. Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis. Neuroradiology 1996;38(suppl 1):S10-13.
46. Rovaris M, Filippi M, Minicucci L, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. Am J Neuroradiol 2000;21:402-8.
47. Lazeron RH, Langdon DW, Filippi M, et al. Neuropsychological impairment in multiple sclerosis patients: the role of (juxta) cortical lesion on FLAIR. Multiple Sclerosis 2000;6:280-5.
48. Sharma R, Narayana PA, Wolinsky JS. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Multiple Sclerosis 2001;7:221-6.
49. Sokic DV, Stojsavljevic N, Drulovic J, et al. Seizures in multiple sclerosis. Epilepsia 2001;42:72-9.
50. Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295-302.
51. Rudick RA, Fisher E, Lee JC, et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698-704.
52. Simon JH. Brain and spinal cord atrophy in multiple sclerosis. Neuroimaging Clin N Am 2000;10:753-70.
53. Simon JH. From enhancing lesions to brain atrophy in relapsing MS. J Neuroimmunol 1999;98:7-15.
54. Simon JH, Jacobs LD, Campion MK, et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1999;53:139-48.
55. Bakshi R, Benedict RH, Bermel RA, et al. Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging 2001;11:129-36.
56. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening ("black T2") in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000;11:15-21.
57. Bakshi R, Dmochowski J, Shaikh ZA, et al. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001;185:19-26.